Economic portfolio
ICICI Prudential Healthcare Fund
ICICI ICICI Prudential Mutual Fund Aug 2026 — Sep 2026 2 months
Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →
Earlier history: this fund was disclosed as ICICI Prudential Pharma Healthcare and Diagnostics Fund up to Jul 2026 (93% the same holdings when it changed).
A renamed or re-coded scheme starts a new history in the disclosures; the two parts are linked here, not merged.
Days to sell half: 34.3 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Large positions in thinly traded stocks: an orderly exit would take weeks or months. Small-cap comparison →
Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.
Sector mix
Share of the equity shown · NSE industry
Funds most like this one
Overlap of disclosed equity · the smaller share of each company both hold, added up
- ICICI Prudential Pharma Healthcare and Diagnostics FundICICI Prudential · 32 shared87.4%
- NIPPON INDIA PHARMA FUNDNippon India · 20 shared55.2%
- UTI - Healthcare FundUTI · 22 shared47.1%
- DSP Nifty Healthcare ETFDSP · 12 shared45.6%
- DSP Nifty Healthcare Index FundDSP · 12 shared45.6%
- ICICI Prudential Nifty Healthcare ETFICICI Prudential · 12 shared45.6%
- Axis NIFTY Healthcare ETFAxis · 12 shared45.6%
- ADITYA BIRLA SUN LIFE NIFTY HEALTHCARE ETFAditya Birla Sun Life · 12 shared45.6%
Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.
What changed in Sep 2026
This portfolio’s consecutive disclosures · evidenced adjustments applied
New positions
Complete exits
- None this month.
Largest increases
- 01 Biocon Limited+24.3% +19.34 L
- 02 Syngene International Limited+14.4% +8.30 L
- 03 Dr. Reddy's Laboratories Limited+8.1% +4.06 L
- 04 Max Healthcare Institute Limited+11.5% +2.00 L
- 05 Medplus Health Services Limited+4.6% +1.97 L
- 06 Pfizer Limited+54.7% +1.52 L
- 07 Cipla Limited+3.2% +91,405
- 08 FDC Limited+4.8% +60,931
- 09 Laxmi Dental Limited+1.4% +33,229
- 10 Lupin Limited+1.5% +9,429
Largest reductions
- 01 Hikal Limited-18.2% -6.64 L
- 02 Indoco Remedies Limited-32.5% -5.40 L
- 03 Akums Drugs and Pharmaceuticals Limited-10.6% -1.91 L
- 04 Entero Healthcare Solutions Limited-37.5% -1.79 L
- 05 Indegene Limited-7.9% -1.74 L
- 06 Mankind Pharma Limited-8.3% -1.25 L
- 07 Alivus Life Sciences Limited-20.2% -1.22 L
- 08 Divi's Laboratories Limited-21.8% -77,560
- 09 Windlas Biotech Limited-11.9% -48,036
- 10 Aarti Drugs Limited-0.5% -9,549
Share quantities, not market values or cash flows.
Holdings by value
Sep 2026 · largest 100 · share of the equity shown
| Company | Sector | Size | Share of equity | Value | Shares held | Held since |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Healthcare | Large Cap | 11.61% | 788 Cr | 0.43 Cr | by Aug 2026 (2 mo+) |
| Dr. Reddy's Laboratories Limited | Healthcare | Large Cap | 9.84% | 668 Cr | 0.54 Cr | by Aug 2026 (2 mo+) |
| Cipla Limited | Healthcare | Large Cap | 5.85% | 397 Cr | 0.29 Cr | by Aug 2026 (2 mo+) |
| Biocon Limited | Healthcare | Mid Cap | 5.39% | 366 Cr | 0.99 Cr | by Aug 2026 (2 mo+) |
| Mankind Pharma Limited | Healthcare | Mid Cap | 5.10% | 346 Cr | 0.14 Cr | by Aug 2026 (2 mo+) |
| Alkem Laboratories Limited | Healthcare | Mid Cap | 4.87% | 330 Cr | 0.06 Cr | by Aug 2026 (2 mo+) |
| Medplus Health Services Limited | Consumer Services | Small Cap | 4.36% | 296 Cr | 0.45 Cr | by Aug 2026 (2 mo+) |
| Cohance Lifesciences Limited | Healthcare | Small Cap | 4.10% | 278 Cr | 0.63 Cr | by Aug 2026 (2 mo+) |
| Divi's Laboratories Limited | Healthcare | Large Cap | 3.82% | 259 Cr | 0.03 Cr | by Aug 2026 (2 mo+) |
| Syngene International Limited | Healthcare | Small Cap | 3.54% | 240 Cr | 0.66 Cr | by Aug 2026 (2 mo+) |
| Dr. Agarwal's Health Care Limited | Not classified | Small Cap | 2.69% | 182 Cr | 0.38 Cr | by Aug 2026 (2 mo+) |
| Max Healthcare Institute Limited | Healthcare | Large Cap | 2.66% | 181 Cr | 0.19 Cr | by Aug 2026 (2 mo+) |
| Abbott India Limited | Healthcare | Mid Cap | 2.57% | 175 Cr | 64,361 | by Aug 2026 (2 mo+) |
| Alembic Pharmaceuticals Limited | Not classified | Small Cap | 2.53% | 171 Cr | 0.21 Cr | by Aug 2026 (2 mo+) |
| Pfizer Limited | Healthcare | Small Cap | 2.45% | 166 Cr | 0.04 Cr | by Aug 2026 (2 mo+) |
| Apollo Hospitals Enterprise Limited | Healthcare | Large Cap | 2.33% | 158 Cr | 0.02 Cr | Sep 2026 (1 mo) |
| Gland Pharma Limited | Healthcare | Small Cap | 1.99% | 135 Cr | 0.05 Cr | Sep 2026 (1 mo) |
| Akums Drugs and Pharmaceuticals Limited | Healthcare | Small Cap | 1.94% | 131 Cr | 0.16 Cr | by Aug 2026 (2 mo+) |
| Lupin Limited | Healthcare | Mid Cap | 1.90% | 129 Cr | 0.06 Cr | by Aug 2026 (2 mo+) |
| AstraZeneca Pharma India Limited | Not classified | Small Cap | 1.87% | 127 Cr | 0.02 Cr | by Aug 2026 (2 mo+) |
| Blue Jet Healthcare Limited | Healthcare | Small Cap | 1.85% | 126 Cr | 0.23 Cr | by Aug 2026 (2 mo+) |
| Indegene Limited | Healthcare | Small Cap | 1.76% | 119 Cr | 0.20 Cr | by Aug 2026 (2 mo+) |
| Metropolis Healthcare Limited | Healthcare | Small Cap | 1.67% | 113 Cr | 0.21 Cr | by Aug 2026 (2 mo+) |
| Rainbow Childrens Medicare Limited | Healthcare | Small Cap | 1.30% | 88.55 Cr | 0.07 Cr | by Aug 2026 (2 mo+) |
| Fine Organic Industries Limited | Not classified | Small Cap | 1.22% | 82.86 Cr | 0.02 Cr | by Aug 2026 (2 mo+) |
| Thyrocare Technologies Limited | Healthcare | Small Cap | 1.18% | 80.16 Cr | 0.15 Cr | by Aug 2026 (2 mo+) |
| Aarti Drugs Limited | Not classified | Small Cap | 1.18% | 79.96 Cr | 0.19 Cr | by Aug 2026 (2 mo+) |
| Medi Assist Healthcare Services Limited | Not classified | Small Cap | 1.07% | 72.77 Cr | 0.24 Cr | by Aug 2026 (2 mo+) |
| Alivus Life Sciences Limited | Not classified | Small Cap | 0.98% | 66.27 Cr | 0.05 Cr | by Aug 2026 (2 mo+) |
| Hikal Limited | Not classified | Small Cap | 0.96% | 64.87 Cr | 0.30 Cr | by Aug 2026 (2 mo+) |
| Sanofi Consumer Healthcare India Limited | Not classified | Small Cap | 0.94% | 64.08 Cr | 0.02 Cr | by Aug 2026 (2 mo+) |
| Manipal Health Enterprises Limited | Not classified | — | 0.88% | 59.96 Cr | 0.08 Cr | by Aug 2026 (2 mo+) |
| Entero Healthcare Solutions Limited | Consumer Services | Small Cap | 0.75% | 50.92 Cr | 0.03 Cr | by Aug 2026 (2 mo+) |
| Laxmi Dental Limited | Not classified | Small Cap | 0.69% | 46.50 Cr | 0.24 Cr | by Aug 2026 (2 mo+) |
| FDC Limited | Not classified | Small Cap | 0.67% | 45.57 Cr | 0.13 Cr | by Aug 2026 (2 mo+) |
| Windlas Biotech Limited | Not classified | Small Cap | 0.57% | 38.85 Cr | 0.04 Cr | by Aug 2026 (2 mo+) |
| Indraprastha Medical Corporation Limited | Not classified | Small Cap | 0.47% | 32.07 Cr | 0.09 Cr | Sep 2026 (1 mo) |
| Indoco Remedies Limited | Not classified | Small Cap | 0.43% | 29.35 Cr | 0.11 Cr | by Aug 2026 (2 mo+) |
| Natco Pharma Limited | Healthcare | Small Cap | 0.02% | 1.36 Cr | 16,439 | Sep 2026 (1 mo) |
Half of its current holdings have been held for 2 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.
Recent position changes
Latest 100 company-month records · evidenced adjustments applied
| Company | Month | Activity | Adjusted change |
|---|---|---|---|
| Biocon Limited | Sep 2026 | ▲ Increasing | +0.19 Cr |
| Indraprastha Medical Corporation Limited | Sep 2026 | ▲ New position | +0.09 Cr |
| Syngene International Limited | Sep 2026 | ▲ Increasing | +0.08 Cr |
| Hikal Limited | Sep 2026 | ▼ Reducing | -0.07 Cr |
| Indoco Remedies Limited | Sep 2026 | ▼ Reducing | -0.05 Cr |
| Gland Pharma Limited | Sep 2026 | ▲ New position | +0.05 Cr |
| Dr. Reddy's Laboratories Limited | Sep 2026 | ▲ Increasing | +0.04 Cr |
| Max Healthcare Institute Limited | Sep 2026 | ▲ Increasing | +0.02 Cr |
| Medplus Health Services Limited | Sep 2026 | ▲ Increasing | +0.02 Cr |
| Apollo Hospitals Enterprise Limited | Sep 2026 | ▲ New position | +0.02 Cr |
| Akums Drugs and Pharmaceuticals Limited | Sep 2026 | ▼ Reducing | -0.02 Cr |
| Entero Healthcare Solutions Limited | Sep 2026 | ▼ Reducing | -0.02 Cr |
| Indegene Limited | Sep 2026 | ▼ Reducing | -0.02 Cr |
| Pfizer Limited | Sep 2026 | ▲ Increasing | +0.02 Cr |
| Mankind Pharma Limited | Sep 2026 | ▼ Reducing | -0.01 Cr |
| Alivus Life Sciences Limited | Sep 2026 | ▼ Reducing | -0.01 Cr |
| Cipla Limited | Sep 2026 | ▲ Increasing | +91,405 |
| Divi's Laboratories Limited | Sep 2026 | ▼ Reducing | -77,560 |
| FDC Limited | Sep 2026 | ▲ Increasing | +60,931 |
| Windlas Biotech Limited | Sep 2026 | ▼ Reducing | -48,036 |
| Laxmi Dental Limited | Sep 2026 | ▲ Increasing | +33,229 |
| Natco Pharma Limited | Sep 2026 | ▲ New position | +16,439 |
| Aarti Drugs Limited | Sep 2026 | ▼ Reducing | -9,549 |
| Lupin Limited | Sep 2026 | ▲ Increasing | +9,429 |
| Dr. Agarwal's Health Care Limited | Sep 2026 | ▲ Increasing | +5,624 |
| AstraZeneca Pharma India Limited | Sep 2026 | ▲ Increasing | +5,224 |
| Sanofi Consumer Healthcare India Limited | Sep 2026 | ▲ Increasing | +3,981 |
Changes compare consecutive month-end disclosures for this portfolio only.